Cargando…

Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition

OBJECTIVE: The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-β1/Smad signal pathway and epithelial to mesenchymal transition (EMT). METHODS: 120 Wistar rats were randomly divided into six...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Lihong, Zhang, Xiaomei, Wang, Hong, Dong, Huan, Gu, Xiaofeng, Yu, Xiaolin, Liu, Yushan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335662/
https://www.ncbi.nlm.nih.gov/pubmed/30719057
http://dx.doi.org/10.1155/2019/2710509
_version_ 1783387930666991616
author Meng, Lihong
Zhang, Xiaomei
Wang, Hong
Dong, Huan
Gu, Xiaofeng
Yu, Xiaolin
Liu, Yushan
author_facet Meng, Lihong
Zhang, Xiaomei
Wang, Hong
Dong, Huan
Gu, Xiaofeng
Yu, Xiaolin
Liu, Yushan
author_sort Meng, Lihong
collection PubMed
description OBJECTIVE: The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-β1/Smad signal pathway and epithelial to mesenchymal transition (EMT). METHODS: 120 Wistar rats were randomly divided into six groups: control group, BLM group, BLM + Pred group, BLM+YYYQ-L group, BLM+YYYQ-M group, and BLM+YYYQ-H group. Rats were given an intratracheal instillation of 3 mg/kg BLM to establish the pulmonary fibrosis model and followed by different dosages of YYYQ (11, 22, 44g/kg, via intragastric gavage) or prednisone soluble (4.2mg/kg, via intragastric gavage) or water. After 14 days and 28 days, tissue sections were stained with hematoxylin-eosin and Masson's trichrome to observe histopathological changes. Protein levels of TGF-β1, CTGF, Interleukin 18, and hydroxyproline were detected by ELISA method, and mRNA expressions of TGF-β1, TβRI, TβRII, Smad3, Smad7, α-SMA, E-cadherin, laminin, and collagen I were detected by RT-PCR. RESULTS: TGF-β1, CTGF, Interleukin 18, and hydroxyproline levels and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I were significantly increased (p <0.01), while Smad7 and E-cadherin levels were significantly decreased in BLM group (p <0.01). YYYQ-M and YYYQ-H group had downregulated the TGF-β1, CTGF, hydroxyproline contents, and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I and upregulated mRNA levels of Smad7 and E-cadherin significantly (p <0.01 or p <0.05). The result from the present study, which was also supported by histological evidence, suggested that YYYQ-M group and YYYQ-H group exhibited better treatment effect on Bleomycin-induced pulmonary fibrotic rats when compared to that of BLM + Pred group (p <0.01). Meanwhile, the effect of YYYQ, in three different dosages, on the level of interleukin 18 was not significant. CONCLUSION: These results showed that YYYQ has the potential of ameliorating the progression of pulmonary fibrosis, and the mechanism may be related to suppressing TGF-β1/Smad signal pathway and EMT in BLM-induced pulmonary fibrosis of rats.
format Online
Article
Text
id pubmed-6335662
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63356622019-02-04 Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition Meng, Lihong Zhang, Xiaomei Wang, Hong Dong, Huan Gu, Xiaofeng Yu, Xiaolin Liu, Yushan Evid Based Complement Alternat Med Research Article OBJECTIVE: The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-β1/Smad signal pathway and epithelial to mesenchymal transition (EMT). METHODS: 120 Wistar rats were randomly divided into six groups: control group, BLM group, BLM + Pred group, BLM+YYYQ-L group, BLM+YYYQ-M group, and BLM+YYYQ-H group. Rats were given an intratracheal instillation of 3 mg/kg BLM to establish the pulmonary fibrosis model and followed by different dosages of YYYQ (11, 22, 44g/kg, via intragastric gavage) or prednisone soluble (4.2mg/kg, via intragastric gavage) or water. After 14 days and 28 days, tissue sections were stained with hematoxylin-eosin and Masson's trichrome to observe histopathological changes. Protein levels of TGF-β1, CTGF, Interleukin 18, and hydroxyproline were detected by ELISA method, and mRNA expressions of TGF-β1, TβRI, TβRII, Smad3, Smad7, α-SMA, E-cadherin, laminin, and collagen I were detected by RT-PCR. RESULTS: TGF-β1, CTGF, Interleukin 18, and hydroxyproline levels and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I were significantly increased (p <0.01), while Smad7 and E-cadherin levels were significantly decreased in BLM group (p <0.01). YYYQ-M and YYYQ-H group had downregulated the TGF-β1, CTGF, hydroxyproline contents, and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I and upregulated mRNA levels of Smad7 and E-cadherin significantly (p <0.01 or p <0.05). The result from the present study, which was also supported by histological evidence, suggested that YYYQ-M group and YYYQ-H group exhibited better treatment effect on Bleomycin-induced pulmonary fibrotic rats when compared to that of BLM + Pred group (p <0.01). Meanwhile, the effect of YYYQ, in three different dosages, on the level of interleukin 18 was not significant. CONCLUSION: These results showed that YYYQ has the potential of ameliorating the progression of pulmonary fibrosis, and the mechanism may be related to suppressing TGF-β1/Smad signal pathway and EMT in BLM-induced pulmonary fibrosis of rats. Hindawi 2019-01-03 /pmc/articles/PMC6335662/ /pubmed/30719057 http://dx.doi.org/10.1155/2019/2710509 Text en Copyright © 2019 Lihong Meng et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Meng, Lihong
Zhang, Xiaomei
Wang, Hong
Dong, Huan
Gu, Xiaofeng
Yu, Xiaolin
Liu, Yushan
Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition
title Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition
title_full Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition
title_fullStr Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition
title_full_unstemmed Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition
title_short Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition
title_sort yangyin yiqi mixture ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting tgf-β1/smad pathway and epithelial to mesenchymal transition
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335662/
https://www.ncbi.nlm.nih.gov/pubmed/30719057
http://dx.doi.org/10.1155/2019/2710509
work_keys_str_mv AT menglihong yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition
AT zhangxiaomei yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition
AT wanghong yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition
AT donghuan yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition
AT guxiaofeng yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition
AT yuxiaolin yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition
AT liuyushan yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition